<ѻý>Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaidѻý> Federal government would pick up about three-fourths of the cost for Medicaid coverage Nov 26, 2024
<ѻý>Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndromeѻý> News and commentary from the endocrinology world Nov 26, 2024
<ѻý>Are GLP-1 Drugs Putting an End to Bariatric Surgery?ѻý> A conversation with bariatric surgeon Christine J. Ren-Fielding, MD Nov 26, 2024
<ѻý>Many Drinkers Cut Back After Starting Obesity Meds, Study Findsѻý> In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
<ѻý>Philly's Tax on Sugary Drinks Did Not Trim Kids' Obesityѻý> "Weight is multifactorial," researcher noted Nov 25, 2024
<ѻý>Even With Access to Blockbuster Obesity Drugs, Some People Don't Lose Weightѻý> "It's discouraging," says one patient Nov 25, 2024
<ѻý>'A Watershed Moment': GLP-1 Drug Succeeds in Late-Stage MASH Trialѻý> First positive phase III study for a GLP-1 agonist in chronic liver disease Nov 20, 2024
<ѻý>GLP-1 Use Prior to Surgery: Analyzing the Updated Guidanceѻý> Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
<ѻý>Metformin Use Linked to Fewer Asthma Attacksѻý> Addition of GLP-1 drugs led to an even greater reduction Nov 19, 2024
<ѻý>75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?ѻý> News and commentary from the endocrinology world Nov 19, 2024
<ѻý>Over 50% of U.S. Adults Qualify for Ozempic, Wegovyѻý> Most are eligible for weight management indication Nov 18, 2024
<ѻý>Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefitѻý> SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
<ѻý>GLP-1 Drugs Could Help People With Alcohol Use Disorderѻý> Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
<ѻý>16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surgeѻý> News and commentary from the endocrinology world Nov 12, 2024
<ѻý>ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugsѻý> Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs Nov 11, 2024
<ѻý>FDA Adds New Warning to GLP-1 Drugsѻý> Labels now caution about pulmonary aspiration risk Nov 08, 2024
<ѻý>Patients With Obesity Shed Pounds With Drug-Free Capsuleѻý> Participants also had improved cardiometabolic measures with Epitomee device Nov 08, 2024
<ѻý>Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancerѻý> Health news and commentary gathered by ѻý staff Nov 08, 2024
<ѻý>Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Yearsѻý> Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
<ѻý>Counter-Marketing Messages Reduced Intent to Drink Sugary Beveragesѻý> Messages about unethical industry practices came with less perceived weight stigma Nov 06, 2024
<ѻý>Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?ѻý> Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
<ѻý>CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Downѻý> News and commentary from the endocrinology world Nov 05, 2024
<ѻý>Weight Loss After Bariatric Surgery in Teens Persisted at 10 Yearsѻý> Remission of coexisting conditions was also maintained, long-term data show Oct 30, 2024
<ѻý>Wegovy Reduced Pain From Knee Osteoarthritisѻý> Patients taking the GLP-1 drug also had greater improvement in physical function Oct 30, 2024
<ѻý>ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patientsѻý> New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
<ѻý>Wegovy Cut Albuminuria by Half in Non-Diabetic CKDѻý> However, 24 weeks of the GLP-1 had no impact on eGFR Oct 29, 2024
<ѻý>GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroidsѻý> GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
<ѻý>Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patientsѻý> Findings leave researcher "concerned" Oct 23, 2024
<ѻý>Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kidsѻý> News and commentary from the endocrinology world Oct 22, 2024
<ѻý>No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonistsѻý> Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
<ѻý>Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suitѻý> Health news and commentary gathered by ѻý staff Oct 22, 2024
<ѻý>Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancerѻý> News and commentary from the endocrinology world Oct 15, 2024
<ѻý>Want to Cut Urate Levels? Try Losing Weightѻý> But Japanese study suggests losses need to be substantial Oct 15, 2024
<ѻý>Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonistsѻý> GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions Oct 14, 2024
<ѻý>Do Lipid Values in Adolescence Improve CVD Risk Prediction?ѻý> Including lipids did not prove superior to non-laboratory-based criteria alone, study finds Oct 14, 2024
<ѻý>Type 2 Diabetes Diagnoses Emerge in Teens Months After COVIDѻý> Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
<ѻý>Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementiaѻý> News and commentary from the endocrinology world Oct 08, 2024
<ѻý>Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved?ѻý> I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
<ѻý>Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equationѻý> Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024